|
|
|
|
| LEADER |
02616nmm a2200289 u 4500 |
| 001 |
EB000629325 |
| 003 |
EBX01000000000000000482407 |
| 005 |
00000000000000.0 |
| 007 |
cr||||||||||||||||||||| |
| 008 |
140122 ||| eng |
| 020 |
|
|
|a 9781468457186
|
| 100 |
1 |
|
|a Hörl, Walter
|e [editor]
|
| 245 |
0 |
0 |
|a New Perspectives in Hemodialysis, Peritoneal Dialysis, Arteriovenous Hemofiltration, and Plasmapheresis
|h Elektronische Ressource
|c edited by Walter Hörl, P.J. Schollmeyer
|
| 250 |
|
|
|a 1st ed. 1989
|
| 260 |
|
|
|a New York, NY
|b Springer US
|c 1989, 1989
|
| 300 |
|
|
|a 218 p
|b online resource
|
| 505 |
0 |
|
|a I New Perspectives in Hemodialysis -- Protein catabolic factors in patients on renal replacement therapy -- ?2 Microglobulin-derived amyloid in dialysis patients -- Mechanisms and consequences of complement activation during hemodialysis -- Neutrophil activation during hemodialysis -- Biocompatibility — a system approach -- Treatment of uremic anaemia with recombinant human erythropoietin -- Endocrine abnormalities in patients with endstage renal failure -- Carnitine supplementation in uremia -- II Pharmacological Therapy in Dialyzed Patients -- Pathophysiology and treatment of hypertension in dialysis patients -- Adjustment of drug dosage to hemodialysis patients -- Pharmacokinetic aspects of drug transport in continuous ambulatory peritoneal dialysis -- Drug therapy during continuous arteriovenous hemofiltration -- III New Perspectives in Peritoneal Dialysis -- The biology of the peritoneal membrane during chronic peritoneal dialysis -- Lymphatic absorption during peritoneal dialysis -- CAPD with bicarbonate solution -- Glucose polymer as an osmotic agent in CAPD -- Effects of long-term treatment with human recombinant erythropoietin in patients on CAPD -- IV New Perspectives in Hemofiltration and Plasmapheresis -- Continuous arterio-venous hemofiltration: Optimization of technical procedures and new directions -- Is continuous haemofiltration superior to intermittent dialysis and haemofiltration treatment? -- Therapeutic apheresis update -- Treatment combining plasmapheresis and pulse cyclophosphamide in severe systemic lupus erythematosus
|
| 653 |
|
|
|a Medicine / Research
|
| 653 |
|
|
|a Biology / Research
|
| 653 |
|
|
|a Biomedical Research
|
| 700 |
1 |
|
|a Schollmeyer, P.J.
|e [editor]
|
| 041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
| 989 |
|
|
|b SBA
|a Springer Book Archives -2004
|
| 490 |
0 |
|
|a Advances in Experimental Medicine and Biology
|
| 028 |
5 |
0 |
|a 10.1007/978-1-4684-5718-6
|
| 856 |
4 |
0 |
|u https://doi.org/10.1007/978-1-4684-5718-6?nosfx=y
|x Verlag
|3 Volltext
|
| 082 |
0 |
|
|a 610.72
|